Option chain shows key data for GlucoTrack's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for GlucoTrack.

GlucoTrack (NASDAQ:GCTK) Stock, Option Chain

GlucoTrack

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an innovative long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

Stock Movers

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AZEK

BTOG

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

New Oriental Education & Technology Group

GCTK

IMTE

LGHL

MGNX

MLGO

NVNI

RNAZ

RZLT

SGLY

SWIN

WINT

Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Intraday Update

ALUR

AUID

BHAT

BNTC

INNV

MCVT

OUST

PNBK

PSTV

RVSB

TNMG

USAR

XHLD

Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Screenshot 2025-03-18 at 5.54.31 PM

Health Care

Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care

GlucoTrack Inc

Advancing Clinical Studies, Meeting Regulatory Milestones, Strengthening Its Strategic Framework And More: The Past Year For Glucotrack, And What Lies Ahead

Press Releases

Glucotrack to Present at TechBio Showcase™ 2025

Management

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Glucotrack Announces ISO 13485:2016 Certification

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Glucotrack Announces Reverse Stock Split

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Aethlon Medical

Autonomix Medical

Aspira Women's Health Inc. - Common Stock

Aspira Womens Health

Bluejay Diagnostics

BioSig Technologies

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

HeartSciences

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

Know Labs

LogicMark

NanoVibronix

NAYA Biosciences

ENDRA Life Sciences

NeuroMetrix

Nuwellis

PAVmed

Predictive Oncology

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

SINTX Techs

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Venus Concept

Catheter Precision

Xylo Technologies Ltd. - American Depositary Shares

Xylo Technologies

Screenshot 2025-02-24 at 6.22.23 PM

Biotech

General

DXCM

Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

Screenshot 2025-01-06 at 6.34.13 PM

Screenshot 2024-12-03 at 7.43.04 PM

Driving Innovation In Diabetes Management: Glucotrack Begins Enrollment For Human Clinical Trials For Its Implantable Continuous Blood Glucose Monitor

Screenshot 2024-10-03 at 5.30.47 PM

SENS

Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology

Screenshot 2024-08-23 at 5.43.44 PM

Poster Presentations, Upcoming Human Trials, Recently Secured Funding And More: Glucotrack&#39;s Plans To Transform The Continuous Glucose Monitoring Market

Movers & Shakers

Continuous Blood Glucose Monitoring Can Materially Improve The Quality Of Life For People With Diabetes – Glucotrack Wants To Make It Easier

Comments

GlucoTrack

GlucoTrack (GCTK) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga